Navigation Links
Monsanto Sees Growing Opportunity for Biotech Traits Globally
Date:9/11/2008

p>"Yield is a priority for farmers," Padgette said. "When we ask farmers today what they want from us in terms of new soybean products, they universally say that they want us to bring the yield improvements they've seen in corn to soybeans."

Padgette will announce that Monsanto's high-yielding soybeans, the first biotech product in soybeans focused solely on improving yield, delivered a 6 to 10 percent yield advantage in the company's recent Latin American trials. The higher-yielding trait, which is part of the yield and stress collaboration with BASF, will be stacked on top of Monsanto's Roundup Ready 2 Yield(TM) soybean platform. Roundup Ready 2 Yield soybeans, which deliver a 7 to 11 percent yield advantage over the popular first generation Roundup Ready(R) technology, recently received regulatory approval in China for importation, placing them one step closer to the expected controlled commercial release on 1 to 2 million acres in 2009.

BASF Collaboration

Next week, Padgette will be speaking at a joint BASF and Monsanto investor event held in Ghent, Belgium. Monsanto's collaboration with BASF works to identify and commercialize novel yield and stress trait technologies for farmers.

"We are extremely pleased with the progress in our yield and stress collaboration with BASF," he said. "Since the start of the collaboration, we have been able to increase the size of our yield and stress transformation pipeline by one-third and have almost 175 field trial locations. Over 90 percent of the genes nominated by BASF have been unique, providing a nice complement to Monsanto's lead genes."

Webcast Information

Padgette's presentation slides and simultaneous audio webcast of the UBS presentation may be accessed by visiting the company's web site at http://www.monsanto.com/investors. Following tomorrow's live broadcast set for 6:30 a.m. CT, a replay of the webcast will be a
'/>"/>

SOURCE Monsanto Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. New Insect Protection Technology From Monsanto Company Deregulated by USDA
2. Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch
3. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
4. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
5. Monsanto Executives to Address Investor Conferences in February
6. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
7. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
8. Monsanto and Devgen Describe New Approach to Insect-Protection
9. Monsanto Company Executives Adopt 10b5-1 Trading Plans
10. Science Magazine Recognizes Monsanto as Top Employer
11. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 VG ... strategic alliance with DAK Renewable Research to conduct ... oil yield. VG Energy is a majority owned ... VGLS). VG Energy,s exclusively licensed compound ... the oil yield in plants, possessing a wide ...
(Date:5/23/2013)... 23, 2013 Virobay, Inc. today announced that ... reached an important milestone, as Virobay has now initiated ... selective cathepsin S inhibitor.   The first ... placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics ... adults. "The initiation of this Phase 1 ...
(Date:5/23/2013)... May 23, 2013 On April 19th ... to supermarkets to search for the growing antibiotic resistant ... Results from a year long study were released late ... foods, specifically meats, over previous years. For those suffering ... growth of antibiotic resistant bacteria in food, may eventually ...
(Date:5/23/2013)... Md. , May 23, 2013 Northwest ... biotechnology company developing DCVax ® personalized immune therapies ... use its exhibit at this year,s American Society Of ... to highlight its leadership role in immune therapy.  ... The ASCO annual meeting is the pre-eminent conference focused ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
... Equity Research, Inc.,(Scimitar) issues a review of Neurobiological ... Treatments, Look at One Stroke,Drug at a Time; ... available at our website: http://www.scimitarequity.com ., ... in the business of acquiring and developing central ...
... Feb. 14 BiPar Sciences, Inc., a,privately held ... Huh, M.D., Ph.D., has been appointed,President and Chief ... on,March 3, 2008., Dr. Huh previously served ... Business Unit at Nektar Therapeutics, a drug development ...
... 14 GeoPharma, Inc. (Nasdaq:,GORX) announced record revenues ... than a 200% increase in sales sequentially, as ... month periods ending,December 31, 2007., "We are ... the,third quarter of our 2008 fiscal year; it ...
Cached Biology Technology:Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc. 2BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer 2GeoPharma Announces Record Revenues in Third Quarter Results 2GeoPharma Announces Record Revenues in Third Quarter Results 3GeoPharma Announces Record Revenues in Third Quarter Results 4GeoPharma Announces Record Revenues in Third Quarter Results 5GeoPharma Announces Record Revenues in Third Quarter Results 6
(Date:5/23/2013)... at Rollins School of Public Health at Emory ... of Technology, have received a $4 million grant ... at Emory University (Health and Exposome Research Center: ... exposome-based center grant awarded in the United States. ... the National Institute of Environmental Health Sciences (NIEHS) ...
(Date:5/23/2013)... Given the implications for the overall health, ... play a primary role in ensuring that all ... 60 minutes per day of vigorous or moderate-intensity ... Institute of Medicine. Recent estimates suggest that ... evidence-based guideline for promoting better health and development. ...
(Date:5/23/2013)... in treating cerebral palsy with autologous cord blood. Following ... year old boy had been in a persistent vegetative ... months after treatment with the cord blood containing stem ... the child learned to speak simple sentences and to ... study, dispel the long-held doubts about the effectiveness of ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3First successful treatment of pediatric cerebral palsy with autologous cord blood 2
... VALLEY, Pa., June 1, 2009 Olympus America Inc. ... NIR, a biliary metallic stent designed with exceptional anatomic ... NIRflex cell design provides a physician support and flexibility; ... pancreatic, liver and bile duct cancers. ...
... how different species are likely to respond to climate ... a species and the interactions between species, in the ... of BioScience , by Eric Post of Pennsylvania ... can be avoided. Their approach, which relies on multi-stage ...
... our cells possess an internal clock, a group of genes ... a day. A large number of circadian genes are expressed ... be precisely regulated over the course of the day. A ... Research Frontiers in Genetics, based at the University of Geneva, ...
Cached Biology News:MicroRNAs grease the cell's circadian clockwork 2
... quick and easy operation of a wide ... The software is fully secure and ... Part 11 regulations, and compatible with user-created ... versatility enables use in high-level research and ...
... We can introduce random mutations to the ... be then cloned into a vector of choice ... Mutation frequency can be set to a ... Number of clones 106-108. Mutations can be ...
... The Freedom EVOlyzer is Tecans new Enzyme-Linked ... microplate processing. Freedom EVOlyzer is a dedicated ... state-of-the art reader, washer and incubation units ... The Freedom EVOlyzer is available in three ...
... The Digital Clamp One can operate as ... as a Conductance (Dynamic) Clamp in electrophysiology research ... as good as conventional analog equipment. This ... advances in the capabilities of Digital Signal Processing ...
Biology Products: